Because of COVID-19’s social distancing safety precautions, many people are not only living in fear of the virus daily, but many are feeling isolated and alone. UConn Today sat down with the Chair of the Department of Psychiatry in the UConn School of Medicine, Dr. David C. Steffens, to learn about the potential health risks of loneliness, especially during the holiday season, and what you can do to improve social connections not only for yourself, but also for your loved ones, especially higher-risk older adults.
Double Down: Election Anxiety on Top of Pandemic Stress
UConn Today sat down with Karen Steinberg, Ph.D., psychologist at the Mood & Anxiety Clinic at UConn Health and associate professor of psychiatry at UConn School of Medicine, to find out what the Clinic’s team of counselors are hearing most from patients in regards to the pandemic-induced stress, and the additional uncertainty and anxiety regarding the outcome of the Nov. 3 U.S. Presidential election.
A Pandemic of Back to School Jitters: What Kids and Parents Can Do
Pandemic or no pandemic, when children are headed back to school it can be quite stressful for them and their parents.
Psychiatric Visits to the Emergency Room Rise Despite the ACA
Emergency room visits in the US for mental health increased every year from 2007 to 2016 despite the expansion of health coverage over that time, researchers – including T. Greg Rhee of the UConn School of Medicine – report on July 28 in the Journal of Clinical Psychiatry.
At Home in CT: Mental Health During COVID
Dr. Kaminer Discusses Addiction and E-cigarette Use Among Young People
Apathy and Reward in Alzheimer’s Disease
Memory loss, confusion, misplacing things – these are all familiar symptoms of Alzheimer’s disease. However, there is actually a more common sign that often goes undetected: apathy.
National Awards for UConn Health Faculty
Dr. Kristina Zdanys was honored as future leader in geriatric psychiatry and the 2019 Clinician Scientist Fellowship Grant has been awarded to Dr. Kevin Manning from the Alzheimer’s Association.
Tech to Assist with Medication Compliance
Depression is a major public health problem affecting over 300 million people worldwide and more than 16 million U.S. adults. Depression patients often struggle with remembering to take their daily medications due to a number of factors including simply forgetfulness.
Nasal Spray Offers Hope for Severely Depressed Patients
Some Connecticut hospitals and doctors and a clinic are starting to treat severely depressed patients with a new nasal spray called Spravato, touted as the most significant federally approved depression medication since Prozac was approved in 1987.